Rafarma Pharmaceuticals Stock Buy Hold or Sell Recommendation
| RAFA Stock | USD 0.09 0.03 47.54% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Rafarma Pharmaceuticals is 'Strong Sell'. Macroaxis provides Rafarma Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RAFA positions.
Check out Rafarma Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Rafarma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Rafarma Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Rafarma |
Execute Rafarma Pharmaceuticals Buy or Sell Advice
The Rafarma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Rafarma Pharmaceuticals. Macroaxis does not own or have any residual interests in Rafarma Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Rafarma Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Rafarma Pharmaceuticals Trading Alerts and Improvement Suggestions
| Rafarma Pharmaceuticals is way too risky over 90 days horizon | |
| Rafarma Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Rafarma Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Rafarma Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (14.85 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rafarma Pharmaceuticals generates negative cash flow from operations |
Rafarma Pharmaceuticals Returns Distribution Density
The distribution of Rafarma Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Rafarma Pharmaceuticals' future price movements. The chart of the probability distribution of Rafarma Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Rafarma Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Rafarma Pharmaceuticals returns is essential to provide solid investment advice for Rafarma Pharmaceuticals.
| Mean Return | 1.72 | Value At Risk | -23.33 | Potential Upside | 33.33 | Standard Deviation | 14.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Rafarma Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Rafarma Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rafarma Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rafarma Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rafarma pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.65 | |
β | Beta against Dow Jones | 0.69 | |
σ | Overall volatility | 15.02 | |
Ir | Information ratio | 0.11 |
Rafarma Pharmaceuticals Volatility Alert
Rafarma Pharmaceuticals is showing large volatility of returns over the selected time horizon. Rafarma Pharmaceuticals is a penny stock. Although Rafarma Pharmaceuticals may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Rafarma Pharmaceuticals. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Rafarma instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Rafarma Pharmaceuticals Fundamentals Vs Peers
Comparing Rafarma Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Rafarma Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Rafarma Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Rafarma Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Rafarma Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Rafarma Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Rafarma Pharmaceuticals to competition |
| Fundamentals | Rafarma Pharmaceuticals | Peer Average |
| Return On Equity | -7.0E-4 | -0.31 |
| Return On Asset | -4.0E-4 | -0.14 |
| Profit Margin | (0.88) % | (1.27) % |
| Operating Margin | (0.81) % | (5.51) % |
| Current Valuation | 7.89 M | 16.62 B |
| Price To Earning | (1.29) X | 28.72 X |
| Price To Sales | 857.77 X | 11.42 X |
| Net Income | (14.85 K) | 570.98 M |
| Book Value Per Share | 40.49 X | 1.93 K |
| Cash Flow From Operations | (1 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Beta | -0.39 | -0.15 |
| Market Capitalization | 110.29 M | 19.03 B |
| Total Asset | 460.33 M | 29.47 B |
| Retained Earnings | (2.38 M) | 9.33 B |
| Current Liabilities | 292 K | 7.9 B |
| Net Asset | 460.33 M |
Rafarma Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Rafarma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 3306.11 | |||
| Daily Balance Of Power | 2.9 | |||
| Rate Of Daily Change | 1.48 | |||
| Day Median Price | 0.085 | |||
| Day Typical Price | 0.0867 | |||
| Price Action Indicator | 0.0195 | |||
| Period Momentum Indicator | 0.029 |
About Rafarma Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Rafarma Pharmaceuticals? Buying financial instruments such as Rafarma Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Rafarma Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Rafarma Pink Sheet
Rafarma Pharmaceuticals financial ratios help investors to determine whether Rafarma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rafarma with respect to the benefits of owning Rafarma Pharmaceuticals security.